Skip to main content
Top
Published in: BMC Women's Health 1/2015

Open Access 01-12-2015 | Research article

Preinvasive and invasive disease in women with cytological diagnosis of high-grade lesion and high-grade lesion cannot exclude microinvasion

Authors: Nina de Siqueira Kuperman, Fábio Bastos Russomano, Yara Lucia Mendes Furtado de Melo, Saint Clair dos Santos Gomes Jr

Published in: BMC Women's Health | Issue 1/2015

Login to get access

Abstract

Background

Cervical cancer is the third most common cancer in Brazil and has a high potential for prevention and cure. The prevalence of invasive and preinvasive disease in women with cytological diagnosis of high-grade lesion – cannot exclude microinvasion (HSIL-micro) is not known.

Methods

This cross-sectional study used a cytology lab database to identify women with HSIL-micro and HSIL referred to two colposcopic units from June 2006 to December 2012. For each woman with HSIL-micro, four women with cytologic diagnosis of HSIL who met the inclusion criteria were identified. Data were obtained from review of medical records.

Results

Forty-seven patients with report of HSIL-micro and 188 patients with report of HSIL were included. The final diagnoses revealed a frequency of preinvasive lesions of 31.9 % (15/47) and 59.6 % (112/188) in patients with HSIL-micro and HSIL, respectively, while the frequency of invasive disease was 63.8 % (30/47) and 11.7 % (22/188), respectively. The HSIL-micro group showed prevalence of preinvasive or invasive disease 6.5 times greater (95 % CI = 1.6-5.7) and, for invasive disease, 2.4 times greater (95 % CI = 1.7-3.6) than the HSIL group.

Conclusion

Higher risk of preinvasive and invasive lesions in women with cytologic diagnosis of HSIL-micro reinforces recommendations for immediate investigation.
Literature
1.
go back to reference IARC Library Cataloguing In Publication Data Cervix Cancer Screening/IARC Working Group on the Evaluation of Cancer-Preventive Strategies. Handbooks of Cancer Prevention. Lyon, France: IARC; 2004. p. 10. IARC Library Cataloguing In Publication Data Cervix Cancer Screening/IARC Working Group on the Evaluation of Cancer-Preventive Strategies. Handbooks of Cancer Prevention. Lyon, France: IARC; 2004. p. 10.
2.
go back to reference Brazil Ministry of Health. Instituto Nacional de Câncer José Gomes de Alencar. Strategic Actions General Coordination. Oncologic Attention Network Support Division. Brazilian Cervical Cancer Screening Guidelines. Rio de Janeiro: INCA; 2011. Brazil Ministry of Health. Instituto Nacional de Câncer José Gomes de Alencar. Strategic Actions General Coordination. Oncologic Attention Network Support Division. Brazilian Cervical Cancer Screening Guidelines. Rio de Janeiro: INCA; 2011.
3.
go back to reference Brazil Ministry of Health. Instituto Nacional de Câncer José Gomes de Alencar. Coordination for Prevention and Surveillance. Brazilian Nomenclature for Cervical Reports and Recommended Management. Rio de Janeiro: INCA; 2006. Brazil Ministry of Health. Instituto Nacional de Câncer José Gomes de Alencar. Coordination for Prevention and Surveillance. Brazilian Nomenclature for Cervical Reports and Recommended Management. Rio de Janeiro: INCA; 2006.
4.
go back to reference Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria end Explanatory Notes. 2nd ed. New York: Springer; 2014. Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria end Explanatory Notes. 2nd ed. New York: Springer; 2014.
5.
go back to reference Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M, et al. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2012;120(1):166–72.CrossRefPubMed Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M, et al. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2012;120(1):166–72.CrossRefPubMed
6.
go back to reference Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol. 1998;91(6):973–6. PubMed.PubMed Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol. 1998;91(6):973–6. PubMed.PubMed
7.
go back to reference Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol. 2001;82(3):516–22.CrossRefPubMed Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol. 2001;82(3):516–22.CrossRefPubMed
8.
go back to reference Dunn TS, Burke M, Shwayder J. A "see and treat" management for high-grade squamous intraepithelial lesion pap smears. J Low Genit Tract Dis. 2003;7(2):104–6.CrossRefPubMed Dunn TS, Burke M, Shwayder J. A "see and treat" management for high-grade squamous intraepithelial lesion pap smears. J Low Genit Tract Dis. 2003;7(2):104–6.CrossRefPubMed
9.
go back to reference Siebers AG, Klinkhamer PJ, Grefte JM, Massuger LF, Vedder JE, Beijers-Broos A, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA. 2009;302(16):1757–64. doi:10.1001/jama.2009.1569. Erratum in: JAMA. 2009 Dec 2;302(21):2322.CrossRefPubMed Siebers AG, Klinkhamer PJ, Grefte JM, Massuger LF, Vedder JE, Beijers-Broos A, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA. 2009;302(16):1757–64. doi:10.​1001/​jama.​2009.​1569. Erratum in: JAMA. 2009 Dec 2;302(21):2322.CrossRefPubMed
10.
go back to reference Longatto-Filho A, Naud P, Derchain SF, Roteli-Martins C, Tatti S, Hammes LS, et al. Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology. Virchows Arch. 2012;460(6):577–85. doi:10.1007/s00428-012-1242-y. Epub 2012 May 5.CrossRefPubMed Longatto-Filho A, Naud P, Derchain SF, Roteli-Martins C, Tatti S, Hammes LS, et al. Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology. Virchows Arch. 2012;460(6):577–85. doi:10.​1007/​s00428-012-1242-y. Epub 2012 May 5.CrossRefPubMed
11.
go back to reference Ingkapairoj N, Luanratanakorn S, Chumworathayi B, Kietpeerakool C, Supoken A. Incidences of cervical intraepithelial neoplasia 2–3 or cancer pathologic diagnoses in patients with a high-grade squamous intraepithelial lesion pap smear attending a colposcopy clinic at srinagarind hospital. Asian Pac J Cancer Prev. 2012;13(12):6203–6.CrossRefPubMed Ingkapairoj N, Luanratanakorn S, Chumworathayi B, Kietpeerakool C, Supoken A. Incidences of cervical intraepithelial neoplasia 2–3 or cancer pathologic diagnoses in patients with a high-grade squamous intraepithelial lesion pap smear attending a colposcopy clinic at srinagarind hospital. Asian Pac J Cancer Prev. 2012;13(12):6203–6.CrossRefPubMed
Metadata
Title
Preinvasive and invasive disease in women with cytological diagnosis of high-grade lesion and high-grade lesion cannot exclude microinvasion
Authors
Nina de Siqueira Kuperman
Fábio Bastos Russomano
Yara Lucia Mendes Furtado de Melo
Saint Clair dos Santos Gomes Jr
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2015
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-015-0239-5

Other articles of this Issue 1/2015

BMC Women's Health 1/2015 Go to the issue